News & Updates

Show Multimedia Only
Metformin plus oral contraceptives an alternative treatment for nonobese women with PCOS

Metformin plus oral contraceptives an alternative treatment for nonobese women with PCOS

07 Mar 2023

In the treatment of polycystic ovary syndrome (PCOS), the combination of metformin plus oral contraceptives appears to benefit women without obesity, inducing favourable effects on glucose metabolism with no further harm on lipid metabolism, according to the results of a meta-analysis.

Metformin plus oral contraceptives an alternative treatment for nonobese women with PCOS

07 Mar 2023
Nitrogen dioxide exposure ups risk of IPF progression

Nitrogen dioxide exposure ups risk of IPF progression

07 Mar 2023

Patients with idiopathic pulmonary fibrosis (IPF) who have high exposure to nitrogen dioxide (NO2) are at greater risk of disease progression, suggests a recent study.

Nitrogen dioxide exposure ups risk of IPF progression

07 Mar 2023
Local plus systemic therapies improve survival in HCC

Local plus systemic therapies improve survival in HCC

07 Mar 2023 byStephen Padilla

Combination therapy using yttrium 90 (Y90) radioembolization and sorafenib/nivolumab for patients with hepatocellular carcinoma (HCC), with hepatic vein (HV) or inferior vena cava (IVC) invasion, results in better outcomes, as indicated by increased response rates, overall survival (OS), and progression-free survival (PFS) benefits, a study has found.

Local plus systemic therapies improve survival in HCC

07 Mar 2023